| Nome |
# |
|
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives, file e0feeaa8-0da5-44d2-e053-6605fe0a8db0
|
155
|
|
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study, file e0feeaa7-9ecb-44d2-e053-6605fe0a8db0
|
153
|
|
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene, file e0feeaa7-a434-44d2-e053-6605fe0a8db0
|
150
|
|
Robotic versus laparoscopic gastrectomy for gastric cancer: an umbrella review of systematic reviews and meta-analyses, file e0feeaaa-4935-44d2-e053-6605fe0a8db0
|
148
|
|
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts, file e0feeaa7-ab0f-44d2-e053-6605fe0a8db0
|
119
|
|
From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model, file e0feeaa8-8f74-44d2-e053-6605fe0a8db0
|
113
|
|
Clinical Outcome of Primary and Postoperative Visceral Perforations, file e0feeaa7-913d-44d2-e053-6605fe0a8db0
|
84
|
|
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: A randomized phase-II trial, file e0feeaa9-8e50-44d2-e053-6605fe0a8db0
|
84
|
|
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses, file e0feeaa9-a7ad-44d2-e053-6605fe0a8db0
|
70
|
|
Pathology Characteristics that Optimize Outcome Prediction of T1N0M0 Breast Cancer, file e0feeaa7-5c7a-44d2-e053-6605fe0a8db0
|
68
|
|
Anatomical vs. Wedge Hepatic Resection. Our Experience about 31 Consecutive Patients with Hepatic Metastases from Colorectal Cancer, file e0feeaa7-63c6-44d2-e053-6605fe0a8db0
|
65
|
|
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases, file e0feeaa4-bdcc-44d2-e053-6605fe0a8db0
|
57
|
|
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal Surface Malignancies Oncoteam—S.I.C.O.’, file e0feeaaa-39c6-44d2-e053-6605fe0a8db0
|
51
|
|
A comprehensive PDX gastric cancer collection captures cancer cell–intrinsic transcriptional MSI traits, file e0feeaab-bb0b-44d2-e053-6605fe0a8db0
|
50
|
|
Experimental Studies on the Modification of Urinary Alanine Aminopeptidase (AAP) and N-Acetyl--D-Glucosaminidase (NAG) in Patients Submitted to Intraperitoneal Hyperthermic Chemoperfusion (HIIP), file e0feeaa7-63c2-44d2-e053-6605fe0a8db0
|
36
|
|
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study, file e0feeaab-cf9b-44d2-e053-6605fe0a8db0
|
31
|
|
Assessment of Microsatellite Instability in Familial Gastric Cancer, file e0feeaa7-9050-44d2-e053-6605fe0a8db0
|
28
|
|
Treatment of Advanced Ovarian Cancer by Neoadjuvant Chemotherapy Followed by Surgical Debulking and Intraperitoneal Chemohyperthermia, file e0feeaa7-9041-44d2-e053-6605fe0a8db0
|
26
|
|
Clinical Utility of Serum Tumor Markers Assay in Patients Admitted for Intestinal Occlusion, file e0feeaa7-5c79-44d2-e053-6605fe0a8db0
|
20
|
|
Age Related Co-Morbidities in Colorectal Cancer Patients: Surgical Problems and Prognostic Impact, file e0feeaa7-913e-44d2-e053-6605fe0a8db0
|
20
|
|
Treatment of Peritoneal Carcinomatosis withCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Personal Experience of the First 100 Cases, file e0feeaa7-90e9-44d2-e053-6605fe0a8db0
|
19
|
|
Correlation between Jaundice and CA 19–9 Serum Levels in Benign and Malignant Conditions, file e0feeaa7-5f18-44d2-e053-6605fe0a8db0
|
17
|
|
Petersen Index Score in Dukes’ B Colorectal Cancer. Our Experience on 210 Consecutive Patients, file e0feeaa7-90ed-44d2-e053-6605fe0a8db0
|
15
|
|
Preoperative Value of Serum 19-9 Levels in Predicting Resectability and Prognosis in Pancreatic Cancer, file e0feeaa7-90ec-44d2-e053-6605fe0a8db0
|
14
|
|
The Emergency Surgery Frailty Index (EmSFI) in Elderly Patients with Acute Appendicitis: An External Validation of Prognostic Score, file 316a1daa-19ca-4a1e-b019-cbf780b8fa4a
|
13
|
|
EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative, file 13a3527b-6534-4985-b34b-7d8110368ef4
|
10
|
|
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status, file e0feeaa7-aa26-44d2-e053-6605fe0a8db0
|
7
|
|
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer, file e0feeaa7-ab0e-44d2-e053-6605fe0a8db0
|
5
|
|
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status, file e0feeaa7-d918-44d2-e053-6605fe0a8db0
|
4
|
|
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience, file e0feeaa5-7402-44d2-e053-6605fe0a8db0
|
3
|
|
C-Met targeting in advanced gastric cancer: An open challenge, file e0feeaa5-746b-44d2-e053-6605fe0a8db0
|
3
|
|
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer, file e0feeaa5-be1e-44d2-e053-6605fe0a8db0
|
3
|
|
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer, file e0feeaa5-bf0f-44d2-e053-6605fe0a8db0
|
3
|
|
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study, file e0feeaa9-6771-44d2-e053-6605fe0a8db0
|
3
|
|
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study, file e0feeaa4-bc7e-44d2-e053-6605fe0a8db0
|
2
|
|
High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study., file e0feeaa4-d061-44d2-e053-6605fe0a8db0
|
2
|
|
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data, file e0feeaa4-d59e-44d2-e053-6605fe0a8db0
|
2
|
|
Subtotal gastrectomy as treatment for distal multifocal early gastric cancer, file e0feeaa4-debf-44d2-e053-6605fe0a8db0
|
2
|
|
Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases, file e0feeaa4-f08d-44d2-e053-6605fe0a8db0
|
2
|
|
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial, file e0feeaa5-7430-44d2-e053-6605fe0a8db0
|
2
|
|
Computed Tomographic Evaluation of Mesentery : Diagnostic Value in Acute Mesenteric Ischemia., file e0feeaa5-99b8-44d2-e053-6605fe0a8db0
|
2
|
|
Gastric cancer: Current status of lymph node dissection, file e0feeaa5-be26-44d2-e053-6605fe0a8db0
|
2
|
|
null, file e0feeaa5-be27-44d2-e053-6605fe0a8db0
|
2
|
|
null, file e0feeaa5-be29-44d2-e053-6605fe0a8db0
|
2
|
|
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015, file e0feeaa5-c221-44d2-e053-6605fe0a8db0
|
2
|
|
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience, file e0feeaa5-c625-44d2-e053-6605fe0a8db0
|
2
|
|
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives, file e0feeaa5-c626-44d2-e053-6605fe0a8db0
|
2
|
|
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study, file e0feeaa6-3854-44d2-e053-6605fe0a8db0
|
2
|
|
Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: An observational study on outcome and microcirculatory changes, file e0feeaa6-ee9a-44d2-e053-6605fe0a8db0
|
2
|
|
Soluble E-Cadherin Level in Gastric Cancer Patients, file e0feeaa7-5c7b-44d2-e053-6605fe0a8db0
|
2
|
|
International consensus on a complications list after gastrectomy for cancer, file e0feeaa7-9fa4-44d2-e053-6605fe0a8db0
|
2
|
|
Complications after gastrectomy for cancer: Italian perspective, file e0feeaa7-9fe7-44d2-e053-6605fe0a8db0
|
2
|
|
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer, file e0feeaa9-9950-44d2-e053-6605fe0a8db0
|
2
|
|
Changing clinical and pathological features of gastric cancer over time., file e0feeaa4-d519-44d2-e053-6605fe0a8db0
|
1
|
|
Trattamento della carcinosi peritoneale mediante citoriduzione chirurgica e chemioipertermia intraperitoneale. [Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy], file e0feeaa4-dccf-44d2-e053-6605fe0a8db0
|
1
|
|
Prospective study of peritoneal recurrence after curative surgery for gastric cancer, file e0feeaa4-df00-44d2-e053-6605fe0a8db0
|
1
|
|
Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1)., file e0feeaa4-e187-44d2-e053-6605fe0a8db0
|
1
|
|
Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer., file e0feeaa4-e762-44d2-e053-6605fe0a8db0
|
1
|
|
The CHOLEGAS study: multicentric randomized, blinded, controlled trial of gastrectomy plus prophylactic cholecystectomy versus gastrectomy only, in adults submitted to gastric cancer surgery with curative intent., file e0feeaa4-e930-44d2-e053-6605fe0a8db0
|
1
|
|
Accuracy of MDCT in preoperative definition of maximum tumor diameter in patients with gastric cancer, file e0feeaa5-0468-44d2-e053-6605fe0a8db0
|
1
|
|
Pancreatic adenocarcinoma in duodenal ectopic pancreas: a case report and review of the literature., file e0feeaa5-1697-44d2-e053-6605fe0a8db0
|
1
|
|
Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes, file e0feeaa5-7405-44d2-e053-6605fe0a8db0
|
1
|
|
Follow-up after gastrectomy for cancer: Results of an international web round table, file e0feeaa5-7a45-44d2-e053-6605fe0a8db0
|
1
|
|
Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection?, file e0feeaa5-7cfe-44d2-e053-6605fe0a8db0
|
1
|
|
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables, file e0feeaa5-7fcf-44d2-e053-6605fe0a8db0
|
1
|
|
Follow-up after gastrectomy for cancer: An appraisal of the Italian research group for gastric cancer, file e0feeaa5-7fd0-44d2-e053-6605fe0a8db0
|
1
|
|
Gastric stump cancer after distal gastrectomy for benign disease: Clinicopathological features and surgical outcomes, file e0feeaa5-81b9-44d2-e053-6605fe0a8db0
|
1
|
|
Short-term and long-term risk factors in gastric cancer, file e0feeaa5-82a8-44d2-e053-6605fe0a8db0
|
1
|
|
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer, file e0feeaa5-bd7b-44d2-e053-6605fe0a8db0
|
1
|
|
The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer, file e0feeaa5-bdeb-44d2-e053-6605fe0a8db0
|
1
|
|
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience, file e0feeaa5-bdef-44d2-e053-6605fe0a8db0
|
1
|
|
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status, file e0feeaa5-bdf0-44d2-e053-6605fe0a8db0
|
1
|
|
null, file e0feeaa5-bdf2-44d2-e053-6605fe0a8db0
|
1
|
|
null, file e0feeaa5-bdf4-44d2-e053-6605fe0a8db0
|
1
|
|
null, file e0feeaa5-bdf6-44d2-e053-6605fe0a8db0
|
1
|
|
null, file e0feeaa5-be21-44d2-e053-6605fe0a8db0
|
1
|
|
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer, file e0feeaa5-be52-44d2-e053-6605fe0a8db0
|
1
|
|
Factors influencing survival after hepatectomy for metastases from gastric cancer, file e0feeaa5-c368-44d2-e053-6605fe0a8db0
|
1
|
|
Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system, file e0feeaa5-c623-44d2-e053-6605fe0a8db0
|
1
|
|
Recurrence after surgery in esophago-gastric junction adenocarcinoma: Current management and future perspectives, file e0feeaa5-d0b6-44d2-e053-6605fe0a8db0
|
1
|
|
Subtotal gastrectomy as treatment for distal multifocal early gastric cancer, file e0feeaa7-9734-44d2-e053-6605fe0a8db0
|
1
|
|
An aggressive early gastric cancer: Kodama's PenA type, file e0feeaa7-9d19-44d2-e053-6605fe0a8db0
|
1
|
|
Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency, file e0feeaa7-a420-44d2-e053-6605fe0a8db0
|
1
|
|
K-RAS mutation in gastric cancer and its link with microsatellite instability status, file e0feeaa7-a424-44d2-e053-6605fe0a8db0
|
1
|
|
Clinical impact of molecular classifications in gastric cancer, file e0feeaa7-a42d-44d2-e053-6605fe0a8db0
|
1
|
|
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study, file e0feeaa7-a460-44d2-e053-6605fe0a8db0
|
1
|
|
The pattern of lymph node metastases in microsatellite unstable gastric cancer, file e0feeaa7-a5bb-44d2-e053-6605fe0a8db0
|
1
|
|
Hereditary diffuse gastric cancer: how to look for and how to manage it, file e0feeaa7-a5bf-44d2-e053-6605fe0a8db0
|
1
|
|
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the “Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network” (SICO-CCN) multicentre collaborative study, file e0feeaa7-a757-44d2-e053-6605fe0a8db0
|
1
|
|
The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients, file e0feeaa7-d917-44d2-e053-6605fe0a8db0
|
1
|
|
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer, file e0feeaa8-91c2-44d2-e053-6605fe0a8db0
|
1
|
|
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer, file e0feeaa8-afce-44d2-e053-6605fe0a8db0
|
1
|
|
A comprehensive PDX gastric cancer collection captures cancer cell–intrinsic transcriptional MSI traits, file e0feeaa9-3049-44d2-e053-6605fe0a8db0
|
1
|
| Totale |
1.725 |